Our results identified PKD as a novel early signaling triggered through CCK or cholinergic receptor to mediate NF-κB activation in acute pancreatitis and demonstrated that PKD inhibitors potently blocked NF-κB activation in in vitro and in vivo experimental pancreatitis models. This evidence concerns the gene NFKB1 and acute pancreatitis.